Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Issues pertaining to repeal of IRC 280E.
Issues pertaining to cannabis CSA scheduling.
Duration: February 1, 2020
to
present
General Issues: Small Business , Taxation/Internal Revenue Code , Medical/Disease Research/Clinical Labs , Banking , Financial Institutions/Investments/Securities , Insurance
Spending: about $880,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Justice - Dept of (DOJ), Drug Enforcement Administration (DEA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2024
In Q2, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on July 1.
Original Filing: 301580868.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2024
In Q1, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on April 2.
Original Filing: 301546128.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2023
In Q4, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Jan. 3.
Original Filing: 301521630.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2023
In Q3, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Oct. 3, 2023.
Original Filing: 301497471.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2023
In Q2, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on July 9, 2023.
Original Filing: 301474019.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2023
In Q1, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on April 4, 2023.
Original Filing: 301448946.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2022
In Q4, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Jan. 7, 2023.
Original Filing: 301425456.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2022
In Q3, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Oct. 5, 2022.
Original Filing: 301401458.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2022
In Q2, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on July 11, 2022.
Original Filing: 301378924.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2022
In Q1, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on April 6, 2022.
Original Filing: 301343970.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2021
In Q4, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Jan. 2, 2022.
Original Filing: 301319713.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2021
In Q3, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Oct. 4, 2021.
Original Filing: 301296511.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2021
In Q2, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on July 2, 2021.
Original Filing: 301273371.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2021
In Q1, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on April 2, 2021.
Original Filing: 301250411.xml
Lobbying Issues
Issues related to cannabis becoming eligible for safe harbor banking, decriminalization and social equity and interstate commerce.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues pertaining to repeal of IRC 280E.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues pertaining to cannabis CSA scheduling.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2020
In Q4, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Jan. 6, 2021.
Original Filing: 301228987.xml
Lobbying Issues
Issues pertaining to making cannabis eligible for SBA and other related programs under COVID/Stimulus legislation, and permitting cannabis to participate in the US banking system without restrictions and full federal legalization in the United States.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on Oct. 4, 2020.
Original Filing: 301207340.xml
Lobbying Issues
Issues pertaining to making cannabis eligible for SBA and other related programs under COVID/Stimulus legislation, and permitting cannabis to participate in the US banking system without restrictions and full federal legalization in the United States.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, The Harris Firm lobbied for Holistic Industries Inc. , earning $50,000. The report was filed on July 7, 2020.
Original Filing: 301185972.xml
Lobbying Issues
Issues pertaining to making cannabis eligible for SBA and other related programs under COVID/Stimulus legislation, and permitting cannabis to participate in the US banking system without restrictions and full federal legalization in the United States.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, The Harris Firm did no lobbying for Holistic Industries Inc. . The report was filed on April 3, 2020.
Original Filing: 301153805.xml
1st Quarter, 2020
The Harris Firm filed a lobbying registration on Jan. 31, 2020 to represent Holistic Industries Inc., effective Feb. 1, 2020.
Original Filing: 301131008.xml
Issue(s) they said they’d lobby about: All issues affecting cannabis industry from FDA and medical to financial such as banking and insurance and other relevant matters. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...